LUMIRADX
LIVE

Serial Number

87103711

Owner

Roche Diagnostics International AG

Attorney

Mona Gupta

Filing Date

Jul 14, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LUMIRADX Trademark

Serial Number: 87103711 • Registration: 6182361

LUMIRADX is a trademark filed by Roche Diagnostics International AG on July 14, 2016. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Roche Diagnostics International AG (3 trademarks)

Forrenstrasse 2

Entity Type: 98

LUMIRADX INTERNATIONAL LTD

London SE12AQ , GB

Entity Type: 99

Trademark Details

Filing Date

July 14, 2016

Registration Date

October 27, 2020

Published for Opposition

July 18, 2017

Goods & Services

Diagnostic, examination and monitoring equipment for medical purposes, namely, apparatus for the detection of infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; medical diagnostic apparatus for the detection of chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; medical diagnostic instruments for detecting chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; diagnostic instruments for medical use for the testing and analysis of assays; [ electronic apparatus for medical purposes for the monitoring of glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; ] analytical instruments for medical use, namely device for [ monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and ] detection of chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; apparatus for carrying-out diagnostic tests for medical purposes, namely [ measurement and ] detection of [ glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of ] chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse ] ; apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of [ glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and ] detection of chronic diseases, infectious diseases [ , cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; diagnostic measuring apparatus for medical use, namely device for monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs, blood counts and blood analysis ] ; apparatus for blood analysis for medical purposes; [ medical instruments for drug abuse testing; medical apparatus for detecting drugs of abuse; ] medical apparatus for detecting and measuring the level of substances in bodily fluids; and parts and fittings for all the aforesaid goods, included in the class

[ Healthcare services; medical diagnostic testing and reporting services; ] providing medical information and advisory services; consulting services in the field of health; medical consulting regarding medical diagnostic apparatus and instruments; [ advice relating to the medical needs of elderly people; ] providing medical advisory services relating to medical instruments; [ providing medical advisory services relating to medical services; medical reporting services, namely, compilation of medical reports; medical analysis services, namely, providing medical record analysis and assessment services designed to provide patients and healthcare professionals with customized diagnostic information, patient diagnoses, medical treatment plans and healthcare management plans; medical health assessment services; medical screening; medical services for the diagnosis of conditions of the human body; medical testing for diagnostic purposes; surgical diagnostic services; health and medical services delivered via online interactive database enabling medical device users to exchange information with healthcare providers; advice, consultancy and information on the aforesaid, included in the class; ] online health and medical services, namely, providing an interactive database for exchanging health and medical information between a medical device user and healthcare providers, delivered via a global computer network

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NURC
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 24, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 24, 2026 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 24, 2026 EROP
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 24, 2026 COC.
TEAS SECTION 7 REQUEST RECEIVED
Apr 24, 2026 ES7R
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Mar 30, 2026 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 30, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 6, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 27, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 13, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 13, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 13, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 13, 2024 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 11, 2024 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 16, 2024 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 7, 2021 ASCK
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2020 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Sep 23, 2020 DP1B
NOTICE OF ALLOWANCE CANCELLED
Sep 11, 2020 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Sep 11, 2020 D1BR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 18, 2020 EXRA
SOU EXTENSION 5 GRANTED
Mar 17, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 17, 2020 AITU
SOU EXTENSION 5 FILED
Mar 9, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 9, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2019 EXRA
SOU EXTENSION 4 GRANTED
Sep 11, 2019 EX4G
SOU EXTENSION 4 FILED
Sep 11, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 11, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2019 EXRA
SOU EXTENSION 3 GRANTED
Mar 11, 2019 EX3G
SOU EXTENSION 3 FILED
Mar 11, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 11, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 11, 2018 EXRA
SOU EXTENSION 2 GRANTED
Aug 9, 2018 EX2G
SOU EXTENSION 2 FILED
Aug 9, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 9, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2018 EXRA
SOU EXTENSION 1 GRANTED
Mar 2, 2018 EX1G
SOU EXTENSION 1 FILED
Mar 2, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 2, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 12, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2017 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jun 14, 2017 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 9, 2017 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 29, 2017 TROA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 8, 2017 ASCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 30, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 30, 2016 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 12, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 12, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 12, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2016 NWOS
NEW APPLICATION ENTERED
Jul 18, 2016 NWAP